Compare PROF & ERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROF | ERC |
|---|---|---|
| Founded | N/A | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.2M | 260.9M |
| IPO Year | 2017 | N/A |
| Metric | PROF | ERC |
|---|---|---|
| Price | $6.94 | $8.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 79.8K | 61.7K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.37% |
| EPS Growth | ★ 25.89 | N/A |
| EPS | 0.19 | ★ 0.72 |
| Revenue | ★ $16,098,000.00 | N/A |
| Revenue This Year | $92.40 | N/A |
| Revenue Next Year | $64.10 | N/A |
| P/E Ratio | $37.95 | ★ $12.55 |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $3.92 | $8.72 |
| 52 Week High | $8.95 | $9.78 |
| Indicator | PROF | ERC |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 37.32 |
| Support Level | $5.81 | $8.90 |
| Resistance Level | $7.07 | $9.49 |
| Average True Range (ATR) | 0.43 | 0.10 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 33.82 | 21.21 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.